Rapid and economical detection of eight carbapenem-resistance genes in Enterobacteriaceae, Pseudomonas spp, and Acinetobacter spp directly from positive blood cultures using an internally controlled multiplex-PCR assay

This was also true for patients undergoing cardiac surgery in the STOP SSI study (cited by Ariyo et al)2 and similar subsequent unpublished studies. In the STOP SSI study, the significant reduction in complex S. aureus SSIs was only seen among orthopedic surgery patients but not cardiac surgery patients. The orthopedic surgery patients tended to be scheduled for elective surgery and had outpatient preoperative clinic visits in the 30 days prior to surgery. During this visit, the orthopedic patients were provided chlorhexidine body wash, were screened for S. aureus colonization and, if positive, were provided with a 5-day supply of mupirocin nasal ointment. In contrast, the cardiac surgery patients did not have a standardized outpatient preoperative clinic appointment and were often only seen in the inpatient setting. Similarly, only 1.6% of patients undergoing urgent/emergent operations were fully adherent to the STOP SSI bundle, 40% of patients undergoing scheduled operations were fully adherent. This factor was reflected in the outcomes, in which there was only a statistically significant reduction in complex S. aureus SSIs among the scheduled operations and not the urgent/emergent operations. In a similar study performed in Veterans Affairs (VA) hospitals, a cardiac case manager from a small VA hospital stated:

[1]  S. Berenholtz,et al.  Implementation strategies to reduce surgical site infections: A systematic review , 2019, Infection Control & Hospital Epidemiology.

[2]  Prateek Shrivastava,et al.  World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics , 2018 .

[3]  F. Codjoe,et al.  Carbapenem Resistance: A Review , 2017, Medical sciences.

[4]  R. Humphries,et al.  Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae , 2017, Virulence.

[5]  A. Cortegiani,et al.  Use of Cepheid Xpert Carba-R® for Rapid Detection of Carbapenemase-Producing Bacteria in Abdominal Septic Patients Admitted to Intensive Care Unit , 2016, PloS one.

[6]  R. Humphries,et al.  Multisite Evaluation of Cepheid Xpert Carba-R Assay for Detection of Carbapenemase-Producing Organisms in Rectal Swabs , 2016, Journal of Clinical Microbiology.

[7]  N. Woodford,et al.  Evaluation of three commercial assays for rapid detection of genes encoding clinically relevant carbapenemases in cultured bacteria. , 2015, The Journal of antimicrobial chemotherapy.

[8]  P. Nordmann,et al.  The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  Y. Glupczynski,et al.  Validation of carbapenemase and extended-spectrum β-lactamase multiplex endpoint PCR assays according to ISO 15189. , 2013, The Journal of antimicrobial chemotherapy.

[10]  B. Millar,et al.  A simple and sensitive method to extract bacterial, yeast and fungal DNA from blood culture material. , 2000, Journal of microbiological methods.